GAM
PLSE icon

Griffin Asset Management’s Pulse Biosciences PLSE Stock Holding History

Griffin Asset Management’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.3M Buy
227,285
+2,108
+0.9% +$49.7K 0.66% 48
2026
Q1 		$4.86M Sell
225,177
-1,135
-0.5% -$20.9K 0.55% 52
2025
Q4 		$3.11M Sell
226,312
-1,000
-0.4% -$15.6K 0.34% 76
2025
Q3 		$4.02M Sell
227,312
-2,347
-1% -$37.1K 0.45% 60
2025
Q2 		$3.47M Sell
229,659
-3,898
-2% -$64.7K 0.41% 70
2025
Q1 		$3.76M Sell
233,557
-3,990
-2% -$74.4K 0.46% 62
2024
Q4 		$4.14M Sell
237,547
-19,902
-8% -$351K 0.49% 56
2024
Q3 		$4.52M Sell
257,449
-230
-0.1% -$3.92K 0.51% 53
2024
Q2 		$2.88M Sell
257,679
-42,641
-14% -$402K 0.33% 71
2024
Q1 		$2.62M Buy
300,320
+40,700
+16% +$374K 0.31% 76
2023
Q4 		$3.18M Sell
259,620
-15,140
-6% -$105K 0.4% 67
2023
Q3 		$1.11M Buy
274,760
+80,410
+41% +$500K 0.16% 120
2023
Q2 		$1.4M Buy
194,350
+25,000
+15% +$160K 0.19% 111
2023
Q1 		$569K Sell
169,350
-6,543
-4% -$19.7K 0.08% 161
2022
Q4 		$487K Buy
175,893
+90,059
+105% +$202K 0.07% 160
2022
Q3 		$197K Buy
85,834
+17,383
+25% +$28.2K 0.03% 198
2022
Q2 		$105K Sell
68,451
-6,400
-9% -$16.1K 0.02% 207
2022
Q1 		$364K Sell
74,851
-1,108
-1% -$9.07K 0.05% 181
2021
Q4 		$1.13M Buy
75,959
+14,488
+24% +$289K 0.14% 134
2021
Q3 		$1.33M Buy
61,471
+3,000
+5% +$64.5K 0.17% 123
2021
Q2 		$959K Hold
58,471
– – 0.12% 146
2021
Q1 		$1.39M Sell
58,471
-28,308
-33% -$846K 0.18% 117
2020
Q4 		$2.07M Buy
86,779
+18,503
+27% +$294K 0.27% 81
2020
Q3 		$805K Buy
68,276
+26,452
+63% +$285K 0.12% 128
2020
Q2 		$437K Sell
41,824
-1,196
-3% -$10.8K 0.07% 156
2020
Q1 		$308K Sell
43,020
-6,765
-14% -$70.2K 0.06% 164
2019
Q4 		$668K Buy
49,785
+1,750
+4% +$24.9K 0.09% 143
2019
Q3 		$742K Sell
48,035
-9,280
-16% -$121K 0.12% 135
2019
Q2 		$757K Buy
57,315
+5,955
+12% +$81.2K 0.1% 162
2019
Q1 		$903K Buy
+51,360
New +$806K 0.13% 150

Other funds holding PLSE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Griffin Asset Management's PLSE Position: Q2 2026 in Review

Griffin Asset Management increased its Pulse Biosciences (PLSE) stake by 0.94% in Q2 2026, buying an estimated $49.7K and bringing the position to 227,285 shares worth $6.3M. The position accounts for 0.66% of the portfolio, ranked #48.

Griffin Asset Management first reported a position in PLSE in Q1 2019 and has held it in 30 quarters since. 106 funds tracked by Wall St. Rank hold PLSE as of Q2 2026.

  • Griffin Asset Management held 227,285 shares of Pulse Biosciences worth $6.3M as of Q2 2026.
  • Griffin Asset Management bought 2,108 Pulse Biosciences shares in Q2 2026, an estimated $49.7K.
  • Pulse Biosciences made up 0.66% of Griffin Asset Management's portfolio in Q2 2026, its #48 holding.
  • Griffin Asset Management first reported a position in Pulse Biosciences in Q1 2019 and has held it in 30 quarters since.
  • 106 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2026.

Based on Griffin Asset Management's 13F filing for Q2 2026, filed 23 Jul 2026.